Publications by authors named "Janice Knowlden"

Claim this Profile
C
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia M W Gee

Breast Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.
Janice M Knowlden, Julia M W Gee, Denise Barrow, John F Robertson, Ian O Ellis

Breast Cancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
Julia M W Gee, Robert I Nicholson, Denise Barrow, Carol M Dutkowski, Lindy Goddard, Janice M Knowlden

Horm Mol Biol Clin Investig· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
Iain R Hutcheson, Lindy Goddard, Denise Barrow, Richard A McClelland, Hayley E Francies, Janice M Knowlden

Breast Cancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Janice M Knowlden, Helen E Jones, Denise Barrow, Julia M W Gee, Robert I Nicholson

Breast Cancer Res Treat· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia M W Gee

Breast Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth factor receptor interplay and resistance in cancer.
Helen E Jones, Julia M W Gee, Iain R Hutcheson, Janice M Knowlden, Denise Barrow

Endocr Relat Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy.
Iain R Hutcheson, Janice M Knowlden, Helen E Jones, Rajpal S Burmi, Richard A McClelland

Endocr Relat Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer.
Neil K Rushmere, Janice M Knowlden, Julia M W Gee, Maureen E Harper, John F Robertson

Int J Cancer· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biology of antihormone failure in breast cancer.
Robert I Nicholson, Julia M W Gee, Janice Knowlden, Richard McClelland, Tracie-Ann Madden

Breast Cancer Res Treat· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination.
Robert I Nicholson, Iain R Hutcheson, Janice M Knowlden, Helen E Jones, Maureen E Harper

Clin Cancer Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAM metalloproteases and EGFR signalling.
Julia M W Gee, Janice M Knowlden

Breast Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Iain R Hutcheson, Janice M Knowlden, Tracie-Ann Madden, Denise Barrow, Julia M W Gee

Breast Cancer Res Treat· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.
Janice M Knowlden, Iain R Hutcheson, Helen E Jones, Tracieann Madden, Julia M W Gee

Endocrinology· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis